Stockscreener 앱 받기
0.8991
5.65%
-0.0464
전일 마감가:
$0.9455
열려 있는:
$0.9041
하루 거래량:
172.88K
Relative Volume:
0.12
시가총액:
$3.52M
수익:
-
순이익/손실:
$-9.34M
주가수익비율:
-0.1259
EPS:
-7.14
순현금흐름:
$-6.69M
1주 성능:
+8.91%
1개월 성능:
-0.66%
6개월 성능:
-40.53%
1년 성능:
-70.94%
1일 변동 폭
$0.862
$0.9115
1주일 범위
$0.845
$1.59
52주 변동 폭
$0.611
$6.65
패인리폼 Stock (PRFX) Company Profile
명칭
Prf Technologies Ltd
전화
-
주소
-
PRFX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRFX
Prf Technologies Ltd
|
0.8998 | 3.70M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
125.08 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.01 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.26 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.84 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
468.05 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
패인리폼 주식(PRFX)의 최신 뉴스
PRF Technologies Files First Patent for AI-Driven Solar Micro-Climate Forecasting - TipRanks
PRF Technologies Files Patent for Advanced Solar Forecasting Software Following Admission to NVIDIA Connect Program - Quiver Quantitative
PRF Technologies Ltd. Files Its First Patent Application for Solar Plant Micro-Climate Forecast Modeling Designed to Improve Energy Production Forecast Accuracy - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Rapt Therapeutics Shares Are Trading Higher By 63%; Here Are 20 Stocks Moving Premarket - Benzinga
PRF Technologies Embraces Multisector Expansion Post-Rebranding - StocksToTrade
PRF Technologies Expands Portfolio with Strategic Rebranding and Healthcare Innovations - timothysykes.com
Merger Talk: What is the PEG ratio of PainReform LtdJuly 2025 Technicals & Trade Opportunity Analysis Reports - baoquankhu1.vn
PRF Technologies Embraces Diversification with Bold Strategic Expansion - StocksToTrade
PRF Technologies Expands Beyond Pharmaceuticals with New Strategic Directions - timothysykes.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
PainReform Stock Spikes As It Rebrands, Expands Beyond Pharma With AI, Clean Energy Push - Benzinga
PainReform PRFX stock jumps in premarket after company rebrands as PRF Technologies - TechStock²
PainReform's Corporate Name Changes To PRF Technologies To Reflect Expansion; Stock Up - Nasdaq
Why PainReform Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket - Benzinga
Gelion PLCProf. Rachid Yazami Appointed Technology Advisor - Research Tree
PRF Technologies rebrands to reflect diversified business model By Investing.com - Investing.com Nigeria
From pain drug to AI solar: PRF Technologies pivots into two big markets - Stock Titan
PainReform Transforms to PRF Technologies, Maintains Ticker PRFX - GuruFocus
PainReform Rebrands as PRF Technologies to Reflect Expansion into Healthcare and AI-Driven Energy - TipRanks
PRF Technologies rebrands to reflect diversified business model - Investing.com
PRF Technologies Ltd. Changes Corporate Name to Reflect Strategic Diversification Amid Growth Initiatives - Quiver Quantitative
PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy Platforms - Weekly Voice
PainReform Ltd. Changes Name to PRF Technologies Ltd. - GlobeNewswire
“To hell with them” – Prof. Frimpong-Boateng fires back at NPP - CitiNewsroom.com
Moving Averages: Is PainReform Ltd impacted by rising ratesWeekly Gains Summary & Technical Confirmation Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
PainReform Reports Positive Phase I Safety Data for OcuRing-K Ocular Drug Platform - TipRanks
PainReform Ltd. and LayerBio, Inc. Announces Safety Data Supporting the Continued Development of OcuRing-K Drop-less, Sustainable-Release Ocular Drug Delivery Platform for Use in Cataract Surgery - marketscreener.com
PainReform’s LayerBio’s Drop-Less OcuRing™-K Delivery Platform Demonstrates Favorable Safety Profile in Preclinical and Phase I Clinical Studies - Sahm
New drop-free eye drug implant shows early safety in cataract surgery - Stock Titan
Ficus Technology Holdings Limited Announces Redesignation of Ir Prof. Young Andrew Meng Cheung as Chief Executive Officer, Effective January 12, 2026 - marketscreener.com
PainReform Ltd. (PRFX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Does PainReform Ltd. stock trade at a discount to peersMarket Growth Summary & High Conviction Buy Zone Picks - Улправда
PainReform (NASDAQ:PRFX) vs. Citius Pharmaceuticals (NASDAQ:CTXR) Financial Comparison - Defense World
What analyst consensus says on PainReform Ltd. stockJuly 2025 Levels & Free Weekly Watchlist of Top Performers - Улправда
Is PainReform Ltd. stock attractive after correctionPortfolio Risk Report & Pattern Based Trade Signal System - ulpravda.ru
PainReform Files Pro Forma Financials Following Majority Acquisition of LayerBio - TipRanks
Tenure-Track Prof./Assoc./Asst. Prof. in Learning Technologies and/or Technology-Enhanced Learning - Times Higher Education
Can PainReform Ltd. stock deliver sustainable ROE2026 world cup usa national team third place match playmakers possession football match prediction preview - Улправда
PainReform Shareholders Approve All Proposals at Adjourned 2026 Annual Meeting - TipRanks
PainReform Ltd's Deepsolar Launches Smart TDD, A Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market - marketscreener.com
PainReform (PRFX) Introduces Advanced Solar Audit Service with S - GuruFocus
PainReform’s DeepSolar Unveils Smart TDD to Speed and Sharpen Solar Asset Due Diligence - TipRanks
PainReform Ltd. Launches Smart TDD: Advanced Solar Technical Due Diligence Service to Enhance Asset Performance and Risk Assessment - Quiver Quantitative
PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market - Yahoo Finance
PainReform Adjourns Annual Shareholder Meeting Due to Lack of Quorum - TipRanks
AI drones join $600B push to keep UAE and Middle East solar farms efficient - Stock Titan
PainReform’s LayerBio platform advances with multi-drug capability - MSN
Is PainReform Ltd stock attractive after correctionWeekly Stock Summary & Weekly Watchlist for Hot Stocks - moha.gov.vn
Why PainReform Ltd. stock remains on buy listsTrade Risk Summary & Daily Oversold Stock Bounce Ideas - Улправда
패인리폼 (PRFX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.61%
0.37%
자본화:
|
볼륨(24시간):